View in EDS

1113P COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib (enco) + binimetinib (bini) vs vemurafenib (vemu) or enco in patients (pts) with BRAF V600–mutant melanoma.

Saved in:
Bibliographic Details
Title: 1113P COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib (enco) + binimetinib (bini) vs vemurafenib (vemu) or enco in patients (pts) with BRAF V600–mutant melanoma.
Authors: Schadendorf, D.1 (AUTHOR), Dummer, R.2 (AUTHOR), Flaherty, K.T.3 (AUTHOR), Robert, C.4 (AUTHOR), Arance Fernandez, A.M.5 (AUTHOR), de Groot, J.W.6 (AUTHOR), Garbe, C.7 (AUTHOR), Gogas, H.8 (AUTHOR), Gutzmer, R.9 (AUTHOR), Krajsova, I.10 (AUTHOR), Liszkay, G.11 (AUTHOR), Loquai, C.12 (AUTHOR), Mandalà, M.13 (AUTHOR), Yamazaki, N.14 (AUTHOR), Guenzel, C.A.15 (AUTHOR), Polli, A.16 (AUTHOR), Thakur, M.17 (AUTHOR), di Pietro, A.18 (AUTHOR), Ascierto, P.A.19 (AUTHOR)
Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS670-S671. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 173099026
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1113P COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib (enco) + binimetinib (bini) vs vemurafenib (vemu) or enco in patients (pts) with BRAF V600–mutant melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Schadendorf%2C+D%2E%22">Schadendorf, D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dummer%2C+R%2E%22">Dummer, R.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Flaherty%2C+K%2ET%2E%22">Flaherty, K.T.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Robert%2C+C%2E%22">Robert, C.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arance+Fernandez%2C+A%2EM%2E%22">Arance Fernandez, A.M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Groot%2C+J%2EW%2E%22">de Groot, J.W.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garbe%2C+C%2E%22">Garbe, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gogas%2C+H%2E%22">Gogas, H.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gutzmer%2C+R%2E%22">Gutzmer, R.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krajsova%2C+I%2E%22">Krajsova, I.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liszkay%2C+G%2E%22">Liszkay, G.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Loquai%2C+C%2E%22">Loquai, C.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mandalà%2C+M%2E%22">Mandalà, M.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yamazaki%2C+N%2E%22">Yamazaki, N.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guenzel%2C+C%2EA%2E%22">Guenzel, C.A.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Polli%2C+A%2E%22">Polli, A.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thakur%2C+M%2E%22">Thakur, M.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22di+Pietro%2C+A%2E%22">di Pietro, A.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ascierto%2C+P%2EA%2E%22">Ascierto, P.A.</searchLink><relatesTo>19</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS670-S671. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173099026
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2023.09.2247
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S670
    Titles:
      – TitleFull: 1113P COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib (enco) + binimetinib (bini) vs vemurafenib (vemu) or enco in patients (pts) with BRAF V600–mutant melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schadendorf, D.
      – PersonEntity:
          Name:
            NameFull: Dummer, R.
      – PersonEntity:
          Name:
            NameFull: Flaherty, K.T.
      – PersonEntity:
          Name:
            NameFull: Robert, C.
      – PersonEntity:
          Name:
            NameFull: Arance Fernandez, A.M.
      – PersonEntity:
          Name:
            NameFull: de Groot, J.W.
      – PersonEntity:
          Name:
            NameFull: Garbe, C.
      – PersonEntity:
          Name:
            NameFull: Gogas, H.
      – PersonEntity:
          Name:
            NameFull: Gutzmer, R.
      – PersonEntity:
          Name:
            NameFull: Krajsova, I.
      – PersonEntity:
          Name:
            NameFull: Liszkay, G.
      – PersonEntity:
          Name:
            NameFull: Loquai, C.
      – PersonEntity:
          Name:
            NameFull: Mandalà, M.
      – PersonEntity:
          Name:
            NameFull: Yamazaki, N.
      – PersonEntity:
          Name:
            NameFull: Guenzel, C.A.
      – PersonEntity:
          Name:
            NameFull: Polli, A.
      – PersonEntity:
          Name:
            NameFull: Thakur, M.
      – PersonEntity:
          Name:
            NameFull: di Pietro, A.
      – PersonEntity:
          Name:
            NameFull: Ascierto, P.A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 10
              Text: 2023 Supplement 2
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 34
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1